Lee-Ming Chuang Selected Research

PXS-4728A

1/2018	Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
1/2018	Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lee-Ming Chuang Research Topics

Disease

54	Type 2 Diabetes Mellitus (MODY) 04/2022 - 11/2002
38	Insulin Resistance 01/2021 - 01/2002
26	Hypertension (High Blood Pressure) 01/2021 - 11/2002
19	Obesity 01/2021 - 11/2002
16	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2019 - 02/2002
9	Inflammation (Inflammations) 06/2021 - 01/2010
9	Neoplasms (Cancer) 01/2021 - 01/2011
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2011
7	Body Weight (Weight, Body) 01/2021 - 02/2004
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 02/2002
6	Diabetes Mellitus 01/2016 - 11/2002
5	Hyperglycemia 01/2020 - 05/2009
5	Atherosclerosis 01/2018 - 05/2009
4	Overweight 01/2021 - 11/2002
4	Infections 10/2019 - 08/2005
4	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 03/2013
3	Heart Failure 02/2017 - 03/2015
3	Weight Loss (Weight Reduction) 09/2016 - 01/2009
3	Proteinuria 01/2016 - 03/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 01/2011
3	Malnutrition (Nutritional Deficiencies) 07/2015 - 06/2013
3	Morbid Obesity 09/2011 - 11/2002
2	Chronic Renal Insufficiency 04/2022 - 01/2021
2	Hyperinsulinism (Hyperinsulinemia) 06/2019 - 11/2002
2	Hypercholesterolemia 06/2019 - 02/2011
2	Hypertriglyceridemia 06/2019 - 02/2016
2	Abdominal Obesity 06/2019 - 02/2014
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 03/2016
2	Pathologic Constriction (Stenosis) 01/2018 - 10/2015
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2017 - 12/2014
2	Birth Weight (Birth Weights) 01/2016 - 06/2010
2	Diabetes Complications 01/2016 - 06/2015
2	Diabetic Nephropathies (Diabetic Nephropathy) 06/2015 - 03/2014
2	Colorectal Neoplasms (Colorectal Cancer) 08/2014 - 05/2012
2	Stomach Neoplasms (Stomach Cancer) 12/2013 - 10/2012
2	Hyperlipidemias (Hyperlipidemia) 06/2013 - 01/2010
2	Nausea 03/2013 - 01/2009
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2013 - 12/2011
2	Liver Neoplasms (Liver Cancer) 07/2012 - 05/2012
1	COVID-19 01/2022
1	Hepatitis B 01/2022

Drug/Important Bio-Agent (IBA)

40	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2002
25	Insulin (Novolin)FDA Link 06/2019 - 01/2002
20	AdiponectinIBA 11/2016 - 02/2002
13	Triglycerides (Triacylglycerol)IBA 06/2019 - 07/2002
11	CholesterolIBA 01/2018 - 09/2004
10	Hemoglobins (Hemoglobin)IBA 04/2022 - 06/2009
10	Aluminum Oxide (Sapphire)IBA 03/2016 - 01/2008
6	Metformin (Glucophage)FDA LinkGeneric 06/2021 - 01/2009
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2006
5	AldehydesIBA 03/2021 - 03/2011
5	LDL CholesterolIBA 01/2021 - 09/2004
5	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2018 - 03/2011
4	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2015
4	LipidsIBA 01/2018 - 09/2004
4	human AOC3 proteinIBA 01/2018 - 05/2009
4	Hypoglycemic Agents (Hypoglycemics)IBA 11/2016 - 07/2012
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 03/2011
4	HDL CholesterolIBA 03/2014 - 07/2002
4	Messenger RNA (mRNA)IBA 12/2013 - 03/2008
3	AlbuminsIBA 01/2021 - 12/2009
3	C-Reactive ProteinIBA 06/2019 - 08/2007
3	Rosiglitazone (Avandia)FDA Link 12/2018 - 05/2012
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018 - 02/2016
3	Amine Oxidase (Copper-Containing)IBA 01/2018 - 09/2013
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2018 - 02/2016
3	Acarbose FDA LinkGeneric 02/2017 - 03/2015
3	ProstaglandinsIBA 01/2016 - 07/2012
3	AmmoniaIBA 01/2016 - 03/2011
3	AminesIBA 01/2016 - 03/2011
3	Uric Acid (Urate)IBA 01/2010 - 11/2002
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 11/2016
2	AcidsIBA 06/2019 - 01/2014
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2018 - 10/2012
2	2,4-thiazolidinedione (thiazolidinedione)IBA 12/2018 - 12/2011
2	Pioglitazone (Actos)FDA Link 12/2018 - 05/2012
2	ThiazolidinedionesIBA 12/2018 - 05/2012
2	ApolipoproteinsIBA 01/2018 - 01/2018
2	Mitochondrial DNA (mtDNA)IBA 01/2018 - 05/2012
2	PXS-4728AIBA 01/2018 - 01/2018
2	Pharmaceutical PreparationsIBA 03/2016 - 06/2009
2	Oxidoreductases (Dehydrogenase)IBA 01/2016 - 10/2012
2	IronIBA 11/2015 - 06/2015
2	CalciumIBA 07/2015 - 06/2015
2	Insulin Glargine (Lantus)FDA Link 04/2015 - 01/2011
2	AdipokinesIBA 01/2014 - 01/2010
2	C-PeptideIBA 06/2013 - 01/2013
2	Exenatide (Byetta)FDA Link 03/2013 - 01/2009
2	Hemoglobin AIBA 03/2011 - 02/2011
2	Adenosine Triphosphate (ATP)IBA 09/2009 - 08/2007
2	VLDL CholesterolIBA 09/2004 - 07/2002
1	VaccinesIBA 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022

Therapy/Procedure

13	Therapeutics 01/2018 - 08/2005
10	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2018 - 02/2011
9	Glycemic Control 01/2021 - 06/2010
2	Surgical Amputation (Amputations) 01/2021 - 11/2012
2	Bariatric Surgery 01/2021 - 01/2013
2	Cesarean Section (Caesarean Section) 01/2016 - 12/2014